APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chronic Idiopathic Constipation (CIC) Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chronic Idiopathic Constipation (CIC) Drugs Industry Growth and Trends Forecast to 2032

Report ID 173977960120 December 2025101 pages

Choose your research edition.

Industry ResearchChronic Idiopathic Constipation (CIC) Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Idiopathic Constipation (CIC) Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Chronic Idiopathic Constipation (CIC) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Idiopathic Constipation (CIC) Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Idiopathic Constipation (CIC) Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Chronic Idiopathic Constipation (CIC) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chronic Idiopathic Constipation (CIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chronic Idiopathic Constipation (CIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Idiopathic Constipation (CIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Idiopathic Constipation (CIC) Drugs include Sanofi, Pfizer, GlaxoSmithKline, Bayer, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Salix Pharmaceuticals, Roche Holding and Progenics Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chronic Idiopathic Constipation (CIC) Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chronic Idiopathic Constipation (CIC) Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Idiopathic Constipation (CIC) Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Idiopathic Constipation (CIC) Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Chronic Idiopathic Constipation (CIC) Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chronic Idiopathic Constipation (CIC) Drugs Market by Company

Sanofi

Pfizer

GlaxoSmithKline

Bayer

Synergy Pharmaceuticals

Sucampo Pharmaceuticals

Salix Pharmaceuticals

Roche Holding

Progenics Pharmaceuticals

Ironwood Pharmaceuticals

Ferring International Center

Chugai Pharmaceutical

Actavis

Chronic Idiopathic Constipation (CIC) Drugs Segment by Type

Lubiprostone

Linaclotide

Others

Chronic Idiopathic Constipation (CIC) Drugs Segment by Application

Ambulatory Surgical Centres

Hospitals & Clinics

Long Term Care Centres

Others

Chronic Idiopathic Constipation (CIC) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Idiopathic Constipation (CIC) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Idiopathic Constipation (CIC) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Idiopathic Constipation (CIC) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chronic Idiopathic Constipation (CIC) Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Chronic Idiopathic Constipation (CIC) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lubiprostone Table 2. Major Company of Linaclotide Table 3. Major Company of Others Table 4. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Chronic Idiopathic Constipation (CIC) Drugs Industry Trends Table 26. Chronic Idiopathic Constipation (CIC) Drugs Industry Drivers Table 27. Chronic Idiopathic Constipation (CIC) Drugs Industry Opportunities and Challenges Table 28. Chronic Idiopathic Constipation (CIC) Drugs Industry Restraints Table 29. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Company (2021-2026) Table 33. Global Chronic Idiopathic Constipation (CIC) Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Chronic Idiopathic Constipation (CIC) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Chronic Idiopathic Constipation (CIC) Drugs Major Company Production Sites and Headquarters Table 36. Global Chronic Idiopathic Constipation (CIC) Drugs Company, Product Type & Application Table 37. Global Chronic Idiopathic Constipation (CIC) Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Chronic Idiopathic Constipation (CIC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 76. Sanofi Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 81. Pfizer Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. Bayer Company Information Table 88. Bayer Business Overview Table 89. Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bayer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 91. Bayer Recent Development Table 92. Synergy Pharmaceuticals Company Information Table 93. Synergy Pharmaceuticals Business Overview Table 94. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 96. Synergy Pharmaceuticals Recent Development Table 97. Sucampo Pharmaceuticals Company Information Table 98. Sucampo Pharmaceuticals Business Overview Table 99. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 101. Sucampo Pharmaceuticals Recent Development Table 102. Salix Pharmaceuticals Company Information Table 103. Salix Pharmaceuticals Business Overview Table 104. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 106. Salix Pharmaceuticals Recent Development Table 107. Roche Holding Company Information Table 108. Roche Holding Business Overview Table 109. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 111. Roche Holding Recent Development Table 112. Progenics Pharmaceuticals Company Information Table 113. Progenics Pharmaceuticals Business Overview Table 114. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 116. Progenics Pharmaceuticals Recent Development Table 117. Ironwood Pharmaceuticals Company Information Table 118. Ironwood Pharmaceuticals Business Overview Table 119. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 121. Ironwood Pharmaceuticals Recent Development Table 122. Ferring International Center Company Information Table 123. Ferring International Center Business Overview Table 124. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 126. Ferring International Center Recent Development Table 127. Chugai Pharmaceutical Company Information Table 128. Chugai Pharmaceutical Business Overview Table 129. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 131. Chugai Pharmaceutical Recent Development Table 132. Actavis Company Information Table 133. Actavis Business Overview Table 134. Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Actavis Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio Table 136. Actavis Recent Development Table 137. North America Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 139. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2021-2026) Table 140. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. North America Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country (2021-2026) Table 145. North America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Chronic Idiopathic Constipation (CIC) Drugs Market Share Forecast by Country (2027-2032) Table 147. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 149. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2021-2026) Table 150. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country (2021-2026) Table 155. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 159. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country (2021-2026) Table 165. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Share Forecast by Country (2027-2032) Table 167. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 169. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2021-2026) Table 170. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 171. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country (2021-2026) Table 175. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 181. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country (2021-2026) Table 185. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Chronic Idiopathic Constipation (CIC) Drugs Distributors List Table 190. Chronic Idiopathic Constipation (CIC) Drugs Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Chronic Idiopathic Constipation (CIC) Drugs Image Figure 2. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (2021-2032) & (K Units) Figure 5. Lubiprostone Image Figure 6. Global Lubiprostone Sales YoY Growth (2021-2032) & (K Units) Figure 7. Linaclotide Image Figure 8. Global Linaclotide Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Chronic Idiopathic Constipation (CIC) Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Ambulatory Surgical Centres Image Figure 26. Global Ambulatory Surgical Centres Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospitals & Clinics Image Figure 28. Global Hospitals & Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Long Term Care Centres Image Figure 30. Global Long Term Care Centres Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Chronic Idiopathic Constipation (CIC) Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Chronic Idiopathic Constipation (CIC) Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Lubiprostone
  • Linaclotide
  • Others
Applications
  • Ambulatory Surgical Centres
  • Hospitals & Clinics
  • Long Term Care Centres
  • Others
Companies covered
  • Sanofi
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Synergy Pharmaceuticals
  • Sucampo Pharmaceuticals
  • Salix Pharmaceuticals
  • Roche Holding
  • Progenics Pharmaceuticals
  • Ironwood Pharmaceuticals
  • Ferring International Center
  • Chugai Pharmaceutical
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Chronic Idiopathic Constipation (CIC) Drugs Market by Type
  6. 1.3.1 Lubiprostone
  7. 1.3.2 Linaclotide
  8. 1.3.3 Others
  9. 1.4 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type
  10. 1.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Chronic Idiopathic Constipation (CIC) Drugs Industry Trends
  2. 2.2 Chronic Idiopathic Constipation (CIC) Drugs Industry Drivers
  3. 2.3 Chronic Idiopathic Constipation (CIC) Drugs Industry Opportunities and Challenges
  4. 2.4 Chronic Idiopathic Constipation (CIC) Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Chronic Idiopathic Constipation (CIC) Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Chronic Idiopathic Constipation (CIC) Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Chronic Idiopathic Constipation (CIC) Drugs Price (2021-2026)
  4. 3.4 Global Chronic Idiopathic Constipation (CIC) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chronic Idiopathic Constipation (CIC) Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Chronic Idiopathic Constipation (CIC) Drugs Company, Product Type & Application
  7. 3.7 Global Chronic Idiopathic Constipation (CIC) Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chronic Idiopathic Constipation (CIC) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chronic Idiopathic Constipation (CIC) Drugs Tier 1, Tier 2, and Tier 3
4 Chronic Idiopathic Constipation (CIC) Drugs Regional Status and Outlook
  1. 4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Historic Market Size by Region
  3. 4.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chronic Idiopathic Constipation (CIC) Drugs by Application
  1. 5.1 Chronic Idiopathic Constipation (CIC) Drugs Market by Application
  2. 5.1.1 Ambulatory Surgical Centres
  3. 5.1.2 Hospitals & Clinics
  4. 5.1.3 Long Term Care Centres
  5. 5.1.4 Others
  6. 5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application
  7. 5.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Synergy Pharmaceuticals
  26. 6.5.1 Synergy Pharmaceuticals Company Information
  27. 6.5.2 Synergy Pharmaceuticals Business Overview
  28. 6.5.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  30. 6.5.5 Synergy Pharmaceuticals Recent Developments
  31. 6.6 Sucampo Pharmaceuticals
  32. 6.6.1 Sucampo Pharmaceuticals Company Information
  33. 6.6.2 Sucampo Pharmaceuticals Business Overview
  34. 6.6.3 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  36. 6.6.5 Sucampo Pharmaceuticals Recent Developments
  37. 6.7 Salix Pharmaceuticals
  38. 6.7.1 Salix Pharmaceuticals Company Information
  39. 6.7.2 Salix Pharmaceuticals Business Overview
  40. 6.7.3 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  42. 6.7.5 Salix Pharmaceuticals Recent Developments
  43. 6.8 Roche Holding
  44. 6.8.1 Roche Holding Company Information
  45. 6.8.2 Roche Holding Business Overview
  46. 6.8.3 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  48. 6.8.5 Roche Holding Recent Developments
  49. 6.9 Progenics Pharmaceuticals
  50. 6.9.1 Progenics Pharmaceuticals Company Information
  51. 6.9.2 Progenics Pharmaceuticals Business Overview
  52. 6.9.3 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  54. 6.9.5 Progenics Pharmaceuticals Recent Developments
  55. 6.10 Ironwood Pharmaceuticals
  56. 6.10.1 Ironwood Pharmaceuticals Company Information
  57. 6.10.2 Ironwood Pharmaceuticals Business Overview
  58. 6.10.3 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  60. 6.10.5 Ironwood Pharmaceuticals Recent Developments
  61. 6.11 Ferring International Center
  62. 6.11.1 Ferring International Center Company Information
  63. 6.11.2 Ferring International Center Business Overview
  64. 6.11.3 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  66. 6.11.5 Ferring International Center Recent Developments
  67. 6.12 Chugai Pharmaceutical
  68. 6.12.1 Chugai Pharmaceutical Company Information
  69. 6.12.2 Chugai Pharmaceutical Business Overview
  70. 6.12.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  72. 6.12.5 Chugai Pharmaceutical Recent Developments
  73. 6.13 Actavis
  74. 6.13.1 Actavis Company Information
  75. 6.13.2 Actavis Business Overview
  76. 6.13.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
  78. 6.13.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
  2. 7.1.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country
  6. 7.2.1 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
  2. 8.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country
  6. 8.2.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
  2. 10.1.1 South America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country
  6. 10.2.1 South America Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Chronic Idiopathic Constipation (CIC) Drugs Value Chain Analysis
  2. 12.1.1 Chronic Idiopathic Constipation (CIC) Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Chronic Idiopathic Constipation (CIC) Drugs Production Mode & Process
  7. 12.2 Chronic Idiopathic Constipation (CIC) Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Chronic Idiopathic Constipation (CIC) Drugs Distributors
  10. 12.2.3 Chronic Idiopathic Constipation (CIC) Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst